Sign in
4

Changes in Ownership

Rapport Therapeutics, Inc. Filed Acc 0001193125-26-167636

10% owner sold 426,005 shares at $40.32 ($17,175,244)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Third Rock Ventures V, L.P. · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-17 Sale : show line 1 in the form 10b5-1 −426,005 $40.32 $17,175,244 6,709,228 D
Open-market sales · 426,005 sh · avg $40.32 · $17,175,244
Loading xslF345X06/ownership.xml…